Immunotherapy for pancreatic cancer boosts survival more than 75 percent in  mice, study finds

Immunotherapy for pancreatic cancer boosts survival more than 75 percent in mice, study finds

4.7
(267)
Write Review
More
$ 17.99
Add to Cart
In stock
Description

The induction of peripheral trained immunity in the pancreas incites anti-tumor activity to control pancreatic cancer progression

Cancers, Free Full-Text

10 Fred Hutchinson Cancer Center

Systemic immunity in cancer

When do we say cure for cancer?

Current Oncology, Free Full-Text

Pharmaceutics, Free Full-Text

A guide to cancer immunotherapy: from T cell basic science to clinical practice

Biomimetic nanoparticles directly remodel immunosuppressive microenvironment for boosting glioblastoma immunotherapy - ScienceDirect

Cancers, Free Full-Text

Immunotherapy for Pancreatic Cancer Boosts Survival by More Than 75% in Mice - CancerConnect

Frontiers Clinical cancer immunotherapy: Current progress and prospects